Integration of technologies for hepatic tissue engineering

被引:116
作者
Nahmias, Yaakov [1 ]
Berthiaume, Francois [1 ]
Yarmush, Martin L. [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Shriners Burn Hosp,Ctr Engn Med,Dept Surg, Boston, MA 02114 USA
来源
TISSUE ENGINEERING II: BASICS OF TISSUE ENGINEERING AND TISSUE APPLICATIONS | 2007年 / 103卷
关键词
D O I
10.1007/10_029
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The liver is the largest internal organ in the body, responsible for over 500 metabolic, regulatory, and immune functions. Loss of liver function leads to liver failure which causes over 25 000 deaths/year in the United States. Efforts in the field of hepatic tissue engineering include the design of bioartificial liver systems to prolong patient's lives during liver failure, for drug toxicity screening and for the study of liver regeneration, ischemia/reperfusion injury, fibrosis, viral infection, and inflammation. This chapter will overview the current state-of-the-art in hepatology including isolated perfused liver, culture of liver slices and tissue explants, hepatocyte culture on collagen "sandwich" and spheroids, coculture of hepatocytes with non-parenchymal cells, and the integration of these culture techniques with microfluidics and reactor design. This work will discuss the role of oxygen and medium composition in hepatocyte culture and present promising new technologies for hepatocyte proliferation and function. We will also discuss liver development, architecture, and function as they relate to these culture techniques. Finally, we will review current opportunities and major challenges in integrating cell culture, bioreactor design, and microtechnology to develop new systems for novel applications.
引用
收藏
页码:309 / 329
页数:21
相关论文
共 137 条
[1]   Structural polarity and functional bile canaliculi in rat hepatocyte spheroids [J].
Abu-Absi, SF ;
Friend, JR ;
Hansen, LK ;
Hu, WS .
EXPERIMENTAL CELL RESEARCH, 2002, 274 (01) :56-67
[2]   Antifibrotic agents for liver disease [J].
Albanis, E ;
Friedman, SL .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) :12-19
[3]   In vitro zonation and toxicity in a hepatocyte bioreactor [J].
Allen, JW ;
Khetani, SR ;
Bhatia, SN .
TOXICOLOGICAL SCIENCES, 2005, 84 (01) :110-119
[4]   Formation of steady-state oxygen gradients in vitro - Application to liver zonation [J].
Allen, JW ;
Bhatia, SN .
BIOTECHNOLOGY AND BIOENGINEERING, 2003, 82 (03) :253-262
[5]   Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities [J].
Andersson, H ;
van den Berg, A .
LAB ON A CHIP, 2004, 4 (02) :98-103
[6]  
Ankoma-Sey V, 1999, NEWS PHYSIOL SCI, V14, P149
[7]   Oxygen Consumption Characteristics of Porcine Hepatocytes [J].
Balis, Ulysses J. ;
Behnia, Kamelia ;
Dwarakanath, Bharath ;
Bhatia, Sangeeta N. ;
Sullivan, Susan J. ;
Yarmush, Martin L. ;
Toner, Mehmet .
METABOLIC ENGINEERING, 1999, 1 (01) :49-62
[8]   Liver fibrosis [J].
Bataller, R ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218
[9]   Xenobiotic metabolism by cultured primary porcine hepatocytes [J].
Behnia, K ;
Bhatia, S ;
Jastromb, N ;
Balis, U ;
Sullivan, S ;
Yarmush, M ;
Toner, M .
TISSUE ENGINEERING, 2000, 6 (05) :467-479
[10]   Is liver fibrosis reversible? [J].
Benyon, RC ;
Iredale, JP .
GUT, 2000, 46 (04) :443-446